Eurobio Scientific has been listed on Euronext Growth Paris (ALERS) since 2005 and is part of the Euronext Growth BPI innovation and Next Biotech indices. It is one of the stock with the highest liquidity on Euronext Growth.
Navigation
Regulated Information
>Half-year results under the liquidity agreement
Half-year financial reports
- Half-year financial report as of June 30, 2020 (in French)
- Half-year financial report as of June 30, 2019 (in French)
- Half-year financial report as of June 30, 2018 (in French)
- Half-year financial report as of June 30, 2017 (in French)
- Half-year financial report as of June 30, 2015 (in French)
- Half-year financial report as of June 30, 2014 (in French)
- Half-year financial report as of June 30, 2013 (in French)
- Half-year financial report as of June 30, 2012 (in French)
Annual financial reports
- Annual financial report at December 31, 2021 (in French)
- Annual financial report at December 31, 2020 (in French)
- Annual financial report at December 31, 2019 (in French)
- Annual financial report at December 31, 2018 (in French)
- Annual financial report at December 31, 2017 (in French)
Half-year results under the liquidity agreement
- Half-year results under the liquidity agreement as of June 30, 2019 (in French)
- Half-year results under the liquidity agreement as of December 31, 2018 (in French)
- Half-year results under the liquidity agreement as of June 30, 2018 (in French)
- Half-year results under the liquidity agreement as of December 31, 2017 (in French)
- Half-year results under the liquidity agreement as of June 30, 2017 (in French)
- Half-year results under the liquidity agreement as of December 31, 2016 (in French)
- Half-year results under the liquidity agreement as of June 30, 2016 (in French)
- Half-year results under the liquidity agreement as of December 31, 2015 (in French)
- Half-year results under the liquidity agreement as of June 30, 2015 (in French)
- Half-year results under the liquidity agreement as of December 31, 2014 (in French)
- Half-year results under the liquidity agreement as of June 30, 2014 (in French)
- Half-year results under the liquidity agreement as of December 31, 2013 (in French)
- Half-year results under the liquidity agreement as of June 30, 2013 (in French)
Auditors fees
Managers transactions
- Managers transactions as of August 30, 2017 (in French)
- Managers transactions as of March 30, 2017 (in French)
- Managers transactions as of February 8, 2017 (in French)
- Managers transactions as of February 7, 2017 (in French)
- Managers transactions as of November 23, 2015 (in French)
- Managers transactions as of May 06, 2015 (in French)
- Managers transactions as of May 14, 2014 (in French)
- Managers transactions as of May 24, 2013 (in French)
- Managers transactions as of May 25, 2012 (in French)
- Managers transaction as of January 4, 2012 (in French)
Voting rights statements
- Voting rights statement as of June 30 2018 (in French)
- Voting rights statement as of May 31 2018 (in French)
- Voting rights statement as of April 30 2018 (in French)
- Voting rights statement as of March 31 2018 (in French)
- Voting rights statement as of February 28 2018 (in French)
- Voting rights statement as of January 31 2018 (in French)
- Voting rights statement as of December 31 2017 (in French)
- Voting rights statement as of November 30 2017 (in French)
- Voting rights statement as of October 31 2017 (in French)
- Voting rights statement as of September 30, 2017 (in French)
- Voting rights statement as of August 31, 2017 (in French)
- Voting rights statement as of July 31, 2017 (in French)
- Voting rights statement as of June 30, 2017 (in French)
- Voting rights statement as of May 31, 2017 (in French)
- Voting rights statement as of April 30, 2017 (in French)
- Voting rights statement as of March 31, 2017 (in French)
- Voting rights statement as of February 28, 2017 (in French)
- Voting rights statement as of January 31, 2017 (in French)
- Voting rights statement as of December 31, 2016 (in French)
- Voting rights statement as of November 30, 2016 (in French)
- Voting rights statement as of October 31, 2016 (in French)
- Voting rights statement as of September 30, 2016 (in French)
- Voting rights statement as of August 31, 2016 (in French)
- Voting rights statement as of July 31, 2016 (in French)
- Voting rights statement as of June 30, 2016 (in French)
- Voting rights statement as of May 31, 2016 (in French)
- Voting rights statement as of April 30, 2016 (in French)
- Voting rights statement as of March 31, 2016 (in French)
- Voting rights statement as of February 29, 2016 (in French)
- Voting rights statement as of January 31, 2016 (in French)
- Voting rights statement as of December 31, 2015 (in French)
- Voting rights statement as of November 30, 2015 (in French)
- Voting rights statement as of September 30, 2015 (in French)
- Voting rights statement as of August 31, 2015 (in French)
- Voting rights statement as of July 31, 2015 (in French)
- Voting rights statement as of June 30, 2015 (in French)
- Voting rights statement as of May 31, 2015 (in French)
- Voting rights statement as of April 30, 2015 (in French)
- Voting rights statement as of March 31, 2015 (in French)
- Voting rights statement as of February 28, 2015 (in French)
- Voting rights statement as of January 31, 2015 (in French)
- Voting rights statement as of December 31, 2014 (in French)
- Voting rights statement as of November 30, 2014 (in French)
- Voting rights statement as of October 30, 2014 (in French)
- Voting rights statement as of September 30, 2014 (in French)
- Voting rights statement as of June 23, 2014 (in French)
Capital increases
- Issue of new shares as of February 19, 2014 under the PACEO® (in French)
- Issue of new shares as of February 5, 2014 under the PACEO® (in French)
- Issue of new shares as of July 15, 2013 under the PACEO® (in French)
- Issue of new shares as of June 10, 2013 under the PACEO® (in French)
- Issue of new shares as of January 25, 2013 under the PACEO® (in French)
Site map - © 2009-2020 Eurobio scientific. All Rights Reserved - Legal information -